Dermal Cell News 5.31 September 16, 2019 | |
| |
TOP STORYUVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma Induction of UVB-derived mutations yielded highly aggressive tumors with decreased anti-tumor activity. However, single-cell-derived tumors with reduced intra-tumor heterogeneity were swiftly rejected. [Cell] Abstract | Press Release | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)DERMAL STEM CELLS & TISSUE REGENERATIONResearchers showed that HNRNPK, a multifunctional protein, was necessary to prevent premature differentiation and sustained the proliferative capacity of epidermal stem and progenitor cells. [Nat Commun] Full Article Investigators demonstrated that secretory phospholipase A2-IIA (sPLA2-IIA) induced rapid proliferation of hair follicle stem cells (HFSCs), thereby altering the proliferation dynamics leading to a complete loss of the slow cycling H2BGFP positive HFSCs. [EBioMedicine] Full Article The authors found that telomere shortening mediated by Terc loss up-regulated Follistatin, inhibiting pSmad signaling and down-regulating P63 and epidermal keratins in an ESC differentiation model as well as in adult development of telomere-shortened mice. [PLoS Genet] Full Article Plasma-activated medium (PAM) promoted melanogenesis through the activation of the enzymes tyrosinase, tyrosinase-related protein-1, and tyrosinase-related protein-2. These effects seemed to be related to reactive oxygen species induced by PAM. [Sci Rep] Full Article The administration of ginkgolide B (GKB) or bilobalide (BB) induced the growth of hair follicles. The viability of dermal papilla cells was also increased by GKB or BB as illustrated by methyl thiazolyl tetrazolium and flow cytometry detection. [BioFactors] Abstract SKIN CANCERS & DISORDERSB Cells Sustain Inflammation and Predict Response to Immune Checkpoint Blockade in Human Melanoma Scientists showed that tumor associated B cells were vital to melanoma associated inflammation. Human B cells expressed pro- and anti-inflammatory factors and differentiated into plasmablast-like cells when exposed to autologous melanoma secretomes in vitro. [Nat Commun] Full Article | Press Release Mechanistically, tryptase was found to be endocytosed by melanoma cells as cargo of DNA-coated exosomes released from melanoma cells, followed by transport to the nucleus. [Cell Death Dis] Full Article Investigators explored novel treatment strategies using clinically approved drugs afatinib (ERBB family inhibitor) and crizotinib (MET inhibitor), to simultaneously block MET and ERBB family receptor tyrosine kinases. [Cell Death Dis] Full Article Subscribe to one of our other 19 science newsletters such as Extracellular Matrix News & Cancer Stem Cell News. | |
| |
REVIEWSPotential of Curcumin in Skin Disorders The authors examined the most relevant in vitro and in vivo studies published to date regarding the use of curcumin in inflammatory, neoplastic, and infectious skin diseases, providing information on its bioavailability and safety profile. [Nutrients] Full Article | Graphical Abstract Visit our reviews page to see a complete list of reviews in the dermal cell research field. | |
| |
INDUSTRY NEWSVerrica Pharmaceuticals Inc. announced that it has submitted a New Drug Application to the FDA for VP-102, a proprietary topical therapy, for the treatment of molluscum contagiosum. [Verrica Pharmaceuticals, Inc.] Press Release Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Bullous Pemphigoid Akari Therapeutics, Plc announced that the FDA has granted orphan drug designation for nomacopan for the treatment of bullous pemphigoid. [Akari Therapeutics, Plc] Press Release | |
| |
POLICY NEWSScience under Maximum Pressure in Iran From travel restrictions and publishing bans to currency collapse, the restoration of US sanctions has left researchers in Iran reeling. [The Scientist] Editorial US EPA to Eliminate All Mammal Testing by 2035 The US Environmental Protection Agency (EPA) in Washington, DC, announced September 10th that it will stop conducting or funding studies on mammals by 2035. The move, which is already eliciting strong reactions from groups supporting or opposing experiments on animals, makes EPA the first federal agency to put a hard deadline on phasing out animal research. [Science Magazine] Editorial
| |
EVENTSNEW NF-kB, JAK-STAT & MAPK in Health, Disease & Therapy Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESScientific Communications Coordinator (STEMCELL Technologies Inc.) Faculty Positions – Cutaneous Oncology and Skin Cancer Research (Columbia University Medical Center) Postdoctoral Researcher – Cancer Research (Champalimaud Foundation) Postdoctoral Position – Cancer Immunology (Northwestern University Feinberg School of Medicine) Faculty Position – Cancer Biology (Children’s Research Institute at UT Southwestern) Faculty Position – Cancer Biology (Emory University) Postdoctoral Research Scholar – Autoimmunity (University of California, Davis) Postdoctoral Fellowship – Gene Therapy of the Human Skin (The University of British Columbia) Postdoctoral Position – Immune Mechanisms of Allergic Diseases (Boston Children’s Hospital) Research Lab Specialist – Tumor Microenvironment & Cell Behavior (University of Southern California) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Dermal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|